Replies to post #4944 on Revance Therapeutics Inc (RVNC)

[edcoolidge]

I'm not necessarily expecting formal guidance, but they obviously won't be able to avoid questions about the outlook in the Q&A.

If the outlook is positive there should be some mention in the press release and prepared statements on the call. If the Q&A is the first time we hear about Q4 and beyond that would be bearish.